Search for Clinical Trial Results
Arteritis - 158 Studies Found
Status | Study |
Terminated |
Study Name: Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis Condition: Giant Cell Arteritis Date: 2011-07-21 Interventions: Drug: Prednisone therapy and pharmacokinetic Prednisone therapy delivered in accordance with a 10 to 18 |
Completed |
Study Name: Hydroxychloroquine in Giant Cell Arteritis Condition: Giant Cell Arteritis Date: 2007-01-31 Interventions: Drug: hydroxychloroquine/placebo |
Completed |
Study Name: Tocilizumab for Patients With Giant Cell Arteritis Condition: Giant Cell Arteritis Date: 2011-10-03 Interventions:
|
Recruiting |
Study Name: Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis Condition: Takayasu's Arteritis Date: 2006-04-14 |
Recruiting |
Study Name: Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis Condition: Takayasu Arteritis Date: 2017-03-13 Interventions:
|
Recruiting |
Study Name: Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis Condition: Takayasu Arteritis Date: 2008-08-29 |
Completed |
Study Name: Impact and Utility of PET Versus Clinical Score for the Assessment of Inflammatory Activity in Takayasu Arteritis Condition: Takayasu Arteritis Date: 2012-02-08 |
Not yet recruiting |
Study Name: Giant Cell Arteritis and Anakinra Trial Condition: Giant Cell Arteritis Date: 2016-07-05 Interventions:
|
Not yet recruiting |
Study Name: Giant Cell Arteritis: Improving Use of Ultrasound Evaluation Condition: Giant Cell Arteritis Date: 2015-08-04 Interventions: Device: Ultrasound of temporal and axillary arteries Each patient will have a clinical assessment and ul |
Recruiting |
Study Name: Baricitinib in Relapsing Giant Cell Arteritis Condition: Arteritis, Giant Cell Date: 2017-01-17 Interventions: Drug: Baricitinib 4 milligrams oral Baricitinib daily for 52 weeks |